Connect with us
Giftify [NASDAQ: GIFT] is disrupting the GLP-1 market with a smart savings model providing consumers with discounted Ozempic and Wegovy. With the FDA closing the loophole...
Gene therapies, including CAR-T, are revolutionizing medicine, with advancements like CRISPR expanding possibilities. Spain excels in transplants and CAR-T access, doubling authorized centers since 2023. Academic...
Researchers discovered a vulnerability in the hepatitis B virus (HBV) that could lead to new treatments. They found that CBL137, a cancer drug, blocks the virus’s...
After a downturn, biotech is rebounding with AI-driven innovation, strong M&A activity, and renewed investor interest. Advances in obesity and cancer treatments, along with AI’s role...
AseBio, alongside Catalan authorities, presented BioSpain 2025, a major biotech event focused on gene therapies, AI, and sustainability. Barcelona will host future editions, reinforcing Spain’s biotech...
The EIB granted Amadix a €15M loan to advance AI-driven blood tests for early cancer detection. Funds will support product development, U.S. validation, and global expansion....
Vytrus Biotech achieved +35% sales growth in 2024, surpassing €5.04M, with strong performance in the US, Europe (+34%), and Latin America (+231%). EBITDA rose 55% to...
KOA Biotech, a Pompeu Fabra University spin-off, raised €2M to develop biosensors for early infection detection in fish farms. Led by Swanlaab, Fund-F, and FABER, the...
CRISPR specialist Akribion Therapeutics, a 2024 spin-off from BRAIN Biotech, raised €8M in seed funding led by CARMA FUND and RV Invest. The funds will support...
AbbVie and Simcere Zaiming announced a licensing option agreement to develop SIM0500, a trispecific antibody targeting multiple myeloma. Currently in Phase I trials, SIM0500 induces strong...
 |
|
 |  |
 |
|